Global public-private partnerships: Part I - A new development in health?

Bulletin of the World Health Organization

Volumn 78, Issue 4, 2000, Pages 549-561

  Buse, K ^a   Walt, G ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Intersectoral cooperation, history; Private sector; Public policy; Public sector; United Nations; World health, trends

Indexed keywords

GLOBAL PERSPECTIVE; HEALTH CARE; PARTNERSHIP APPROACH; UNITED NATIONS;

ARTICLE; HEALTH CARE POLICY; ORGANIZATION; POLICY; UNITED NATIONS; WORLD HEALTH ORGANIZATION;

INTERNATIONAL AGENCIES; INTERNATIONAL COOPERATION; PRIVATE SECTOR; PUBLIC POLICY; PUBLIC SECTOR; WORLD HEALTH;

EID: 0034121609     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (90)

1. Pearson LB. Partners in development: Report of the Commission on International Development. London: Commission on International Development, 1969.
2. Shaping the 21st century: the contribution of development cooperation. Paris OECD, 1996.
3. Kickbusch I, Quick J. Partnerships for health in the 21st century. World Health Statistics Quarterly. 1998, 51: 68-74.
4. WHO guidelines on collaboration and partnerships with commercial enterprises. Geneva, World Health Organization, 1999 (Draft discussion document, 24 June 1999).
5. Partnership for development: proposed actions for the World Bank. Washington, DC, World Bank (Discussion paper, Partnerships Group, 20 May 1998).
6. Partnerships with business. London, Department for International Development, 1999.
7. Eliminating world poverty: a challenge for the 21st century. London, Department for International Development, 1997.
8. Walt G et al. Managing external resources in the health sector: are there lessons for SWAps? Health Policy and Planning. 1999, 14: 273-284.
9. The ties that bind? Weighing the risks and benefits of pharmaceutical industry sponsorship. Amsterdam, Health Action International, 1999 (Seminar Report).
10. Yach D. Personal communication, 28 July 1999.
11. Helping to correct the 10/90 gap: an overview, Global Forum for Health Research, Geneva, 1999.
12. Widdus R, Evans P. Lessons learned from the Children's Vaccine Initiative 1990-1999. Paper presented at: Third Global Forum for Health Research, Geneva, 9 June 1999.
13. Frost L, Reich M. Mectizan donation program: Origins, experiences, and relationships with co-ordinating bodies for onchocerciasis control. Boston, MA, Harvard School of Public Health, 1998.
14. The Malarone donation program: A story of partnership. Update 1. Cecatur, Georgia, Malarone Donation Program, Decembe 1998.
15. WHO launches partnership with the pharmaceutical Industry to help smokers Geveva, World Health Organization, Press Release WHO/4, 30 January 1999.
16. Fathalla MF. Contraception-21. Special Supplement on 'Contraception-21: The promise of private/public-sector collaboration, Journal of Gynaecology and Obstetrics (in press).
17. Willetts P. Pressure groups in the global system. London, Frances Pinter, 1982.
18. Mitchell-Weaver C, Manning B. Public-private partnerships in Third World development. The 20th Norma Wilkinson Memorial Lecture. Reading, Reading University, 1990.
19. Babai D. The World Bank and the IMF: rolling back the state or backing its role? In Vernon R, ed. The promise of privatisation: a challenge for American foreign policy. New York, Council on Foreign Relations, 1988: 254-285.
20. The Bank's relationship with NGOs: Issues and directions. Washington, DC, World Bank, 1998.
21. Sikkink K. Codes of conduct for transnational corporations: the case of the WHO/UNICEF code. International Organisation, 1986, 40 (4): 817-840.
22. Kanji N et al. Drugs policy in developing countries. London, Zed Books, 1992.
23. Repositioning the WHO. The Economist, May 1998.
24. Mills A. Leopard or chameleon? The changing character of international health economics. Tropical Medicine and International Health, 1997, 2: 963-977.
25. Dukes G. The contribution of the private sector: an introduction. Australian Prescriber, 1997, 20 (Suppl. 1): 74-75.
26. Peters G. Third party governments and public-private partnerships. Pittsburgh, PA, University of Pittsburgh, 1987.
27. Giddens A. The third way: the renewal of social democracy. Cambridge, Polity Press, 1998.
28. Goodfield J. A chance to live: the heroic story of the global campaign to immunize the world's children. New York, MacMillan, 1991.
29. Ridley R, Gutteridge WE, Currat LJ. New Medicines for Malaria Venture: a case study of the establishment of a public sector - private sector partnership. Paper presented at: Third Global Forum for Health Research, Geneva, 8-11 June 1999.
30. Beigbeder Y. Another role for an NGO: Financing a WHO programme - Rotary International and the eradication of poliomyelitis. Paper presented at: ACUNS Ninth Annual Meeting, Turin, Italy, 24-26 June 1996.
31. Harrison P, Lederberg J. Orphans and incentives: developing technologies to address emerging infections. Washington, DC, Institute of Medicine, National Academy Press, 1997.
32. Lucas A. Personal communication, 13 July 1999.
33. Batson A. Win-win interactions between the public and private sectors. Nature Medicine Vaccine Supplement, 1998, 4 (5): 487-491.
34. Mahoney RT, Maynard JE. The introduction of new vaccines into developing countries Vaccine, 1999, 17 (7-8): 646-652.
35. Pecoul B et al. Access to essential drugs in poor countries: a lost battle? Journal of the American Medical Association, 1999, 281: 361-367.
36. Intellectual property rights: summary report and recommendations of an international meeting, 13 August 1996. New York, International AIDS Vaccine Initiative, 1996.
37. Olliario P. Will the fight against tropical disease benefit from orphan drug status? Tropical Medicine and International Health, 1997, 2: 113-115.
38. Tarabusi CC, Vickery G. Globalisation in the pharmaceutical industry: Part I. International Journal of Health Services, 1998, 28: 67-105.
39. Tarabusi CC, Vickery G. Globalisation in the pharmaceutical industry: Part II. International Journal of Health Services, 1998, 28: 281-303.
40. Batson A, Evans P, Milstien JB. The crisis in vaccine supply: a framework for action. Vaccine, 1994, 12: 963-965.
41. The CVI strategic plan - managing opportunity and change: a vision of vaccination for the 21st century. Geneva, Children's Vaccine Initiative, 1998.
42. IAVI launches campaign for Global HIV Vaccine Purchase Fund. New York, International AIDS Vaccine Initiative Report, April-June 1998, 3 (2).
43. Cattaui MS. Business and the UN: common ground. ICC Business World. Paris, 3 August 1998.
44. No hiding place: business and the politics of pressure. London, Control Risks Group (unpublished paper, 1997).
45. Wapner P. Politics beyond the State: environmental activism and world civic politics. World Politics, 1995, 47: 311-340.
46. Vidal J. How Monsanto's mind was changed. The Guardian, 9 October 1999.
47. Auty R. Remarks made at parallel session number 7.1 at: Third Global Forum for Health Research, 8 June 1999, Geneva.
48. Wehrein P. Pharmaco-Philanthropy. Harvard Public Health Review, Summer 1999: 32-39.
49. UN and private sector need each other - Kofi Annan. ICC Business World, 23 September 1998.
50. Unite power of markets with authority of universal values, Secretary-General urges at World Economic Forum. Press Release SG/SM/6448. New York, United Nations, 30 January 1998.
51. Joint Statement on Common Interests by UN Secretary-General and International Chamber of Commerce. Press Release SG/2043. New York, United Nations, 9 February 1998.
52. Secretary-General proposes global compact on human rights, labour, environment in address to World Economic Forum in Davos. Press Release SG/SM/6881. New York, United Nations, 1 February 1999.
53. Cattaui MS. Business community takes up Kofi Annan's challenge. Press Release, Paris, International Chamber of Commerce, 15 March 1999.
54. The Geneva business dialogue. Business, WTO and UN: joining hands to deregulate the global economy? Corporate Europe Observatory, 1998. Internet communication, July 1999 at http://www.globalpolicy.org/socecon/tncs/maucher.htm
55. Business works with UNTAD to boost investment in Africa. UNCTAD Press Release. TAD/INF/2789. Geneva, UNCTAD, 19 January 1999.
56. The globalsustainable development facility. Internal document. New York, United Nations Development Programme, July 1998.
57. Karliner J et al. A perilous partnership: The United Nations Development Programme's flirtation with corporate collaboration. The Transnational Resource and Action Centre. Internet Communication, 12 March 1999 at http://www.corpwatch.org
58. Baxi U et al. Letter to James Speth, UNDP Administrator, 12 March 1999.
59. Klein N. UN pact with business masks real dangers. Toronto Star, 19 March 1999.
60. Klein N. The UN is losing sight of its goals. Toronto Star, 26 March 1999.
61. UNICEF: Bellamy warns against partnerships with private sector. UN Wire, Internet communication, 23 April 1999 at http:// www.unfoundation.org/unwire/archives/UNWIRE990423.cfm#2
62. Vitamin A: private companies to aid fortification effort. UN Wire, Internet communication, 17 March 1999 at http://www. unfoundation.org/unwire/archives/UNWIRE990317.cfm#6
63. Bellamy C. Public, private and civil society. Statement of UNICEF Executive Director to Harvard International Development Conference: Sharing responsibilities: public, private and civil society, Harvard University, Cambridge, MA, 16 April 1999.
64. Business partners for development. Undated document. Internet communication, 3 March 1999 at http://www.bpdweb.org/ overview.htm
65. Wolfenson J. Business partners for development. Speech to: World Bank Group Board Meeting on Corporate Citizenship, Washington, DC, 21 May 1997.
66. WHO/Private sector talks. Press Release WHO/64, Geneva, World Health Organization, 30 September 1998.
67. Brundtland GH. WHO - the way ahead. Statement by the Director-General to the 103rd Session of the Executive Board. Geneva, World Health Organization, 25 January 1999.
68. Press Release WHO/3. Geneva, World Health Organization, 15 January 1996.
69. WHO and pharmaceutical industry to set up joint working group. Press Release WHO/75. Geneva, World Health Organization, 22 October 1998.
70. Buse K, Walt G. Global public-private health partnerships: part II - what are the issues for global governance? Bulletin of the World Health Organization, 2000, 78 (in press).
71. Leading companies to mobilize against global AIDS epidemic. Press Release. Geneva, UNAIDS, 23 October 1997.
72. UNAIDS launches initiative to help bridge gap in access to HIV/ AIDS-related drugs in developing world. Press Release. Geneva, UNAIDS, 5 November 1997.
73. HIV/AIDS: drug company to spend $ 100 million in Southern Africa. Comments attributed to SG Cowal of UNAIDS. UN Wire, Internet communication, 6 May 1999 at http://www. unfoundation.org/unwire/archives/UNWIRE990506.cfm#4
74. Bristol-Myers Squibb "Secure the Future" announcement and media reaction. Internet posting from the Treatment Access Forum. Internet communication, 11 May 1999 at http:// www.hivnet.ch:8000/treatment-access/tdm
75. Letter from SG Cowal, Director of External Relations, UNAIDS, to undisclosed recipient. Geneva, UNAIDS, 1999.
76. UNAIDS plan spurs sale of millions of female condoms. Press Release. Geneva, UNAIDS, 17 April 1998.
77. Bristol-Myers Squibb commits $ 100 million for HIV/AIDS Research and Community Outreach in Five African Countries. Press Release. Washington, DC, 6 May 1999.
78. Maucher HO. The Geneva business declaration. Geneva, International Chamber of Commerce, 24 September 1998.
79. Cattaui MS. Business partnership forged on global economy. ICC Press Release. Paris, 6 February 1998.
80. Lee K, Humphreys D, Pugh M. "Privatisation" in the United Nations system: patterns of influence in three intergovernmental organisations. Global Society, 1997, 11 (3): 339-357.
81. Vogel D. The globalisation of pharmaceutical regulation. Governance, 1998, 11: 1-22.
82. Bond P. Globalisation, pharmaceutical pricing and South Africa health policy: managing confrontation with US firms and politicians. Johannesburg, Witwatersrand University, 1999 (Unpublished draft paper).
83. Chaparro E, Gevers C. The new corporate citizens: Investing in communities makes for good business. Undated document. Internet communication, July 1999 at http://www.worldbank.org/ bdp/achives/article.htm (no longer available).
84. Colatrella BD. Corporate donations. Annals of Tropical Medicine and Parasitology, 1998, 92:153.
85. The Meclizan R Donation Program Milestones. Dactur, GA, Mectizan Donation Program, Merck & Co., December 1998.
86. World Bank, SmithKline Beecham and WHO to co-operate on elephantiasis elimination. News Release No. 98/1623. Washington, DC, World Bank, 26 January 1998.
87. Bristol Myers grant update. UN Wire, Internet communication, 26 May 1999 at http://www.unfoundation.org/unwire/archives/ UNWIRE990526.cfm#5
88. DeRoeck D, Levin A. A review of financing immunization programs in developing and transitional countries. Bethesda, MD, Partnerships for Health Report Project, Abt Associates, Inc, 1998 (Special Initiatives Report No. 12).
89. Shretta R. The goodwill pill - policies and politics of drug donations. Malarone: a case study. London School of Hygiene and Tropical Medicine, June 1999 (unpublished presentat on).
90. Collatrella BD. Personal communication, 29 July 1999.